SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Global Insight Services | PRODUCT CODE: 2130710

Cover Image

PUBLISHER: Global Insight Services | PRODUCT CODE: 2130710

Remote Patient Monitoring for Chronic Illness Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Component, Application, Device, Deployment, End User

PUBLISHED:
PAGES: 350 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 4750
PDF & Excel (Site License)
USD 5750
PDF & Excel (Enterprise License)
USD 6750

Add to Cart

The global Remote Patient Monitoring for Chronic Illness Market is projected to grow from $4.5 billion in 2025 to $9.2 billion by 2035, at a compound annual growth rate (CAGR) of 7.3%. Growth is driven by increasing chronic disease prevalence, advancements in telehealth technology, and rising demand for cost-effective healthcare solutions. The Remote Patient Monitoring for Chronic Illness Market is characterized by a moderately consolidated structure, with the top segments being cardiovascular monitoring systems, accounting for approximately 35% of the market share, followed by diabetes management systems at 30%, and respiratory monitoring systems at 20%. Key applications include home healthcare, long-term care facilities, and hospitals. The market is witnessing a steady increase in installations, driven by the rising prevalence of chronic diseases and the adoption of telehealth solutions.

The competitive landscape features a mix of global and regional players, with global companies such as Philips Healthcare and Medtronic leading the market. Innovation is high, with companies investing in AI-driven analytics and wearable technology to enhance patient monitoring capabilities. There is a notable trend towards mergers and acquisitions, as well as strategic partnerships, aimed at expanding product portfolios and geographic reach. These collaborations are crucial for companies to maintain competitiveness and meet the growing demand for integrated healthcare solutions.

Market Segmentation
TypeWearable Devices, Implantable Devices, External Monitoring Devices, Others
ProductBlood Glucose Monitors, Cardiac Monitors, Respiratory Monitors, Blood Pressure Monitors, Temperature Monitors, Multi-parameter Monitors, Others
ServicesConsultation Services, Installation Services, Maintenance Services, Training Services, Data Management Services, Others
TechnologyBluetooth, Wi-Fi, Cellular Networks, Zigbee, Others
ComponentSensors, Software, Connectivity Technology, Others
ApplicationDiabetes Management, Cardiovascular Disease Management, Respiratory Disease Management, Hypertension Management, Others
DeviceSmartwatches, Fitness Trackers, Implantable Loop Recorders, Continuous Glucose Monitors, Others
DeploymentCloud-based, On-premise, Others
End UserHospitals, Home Care Settings, Ambulatory Care Centers, Long-term Care Centers, Others

In the Type segment, wearable devices and remote monitoring systems are the primary drivers of market growth. Wearable devices, such as smartwatches and biosensors, dominate due to their ability to continuously collect health data, providing real-time insights into patient conditions. The demand is fueled by the increasing prevalence of chronic diseases like diabetes and cardiovascular disorders, which require constant monitoring. The integration of AI and IoT technologies into these devices is a notable trend, enhancing their functionality and user experience.

The Technology segment is led by wireless communication technologies, particularly Bluetooth and Wi-Fi, which facilitate seamless data transmission between patients and healthcare providers. These technologies are crucial for enabling remote monitoring and timely interventions. The growing adoption of cloud-based platforms for data storage and analysis is driving this segment, as they offer scalability and accessibility. The trend towards interoperability and integration with electronic health records (EHRs) is also significant, improving the efficiency of healthcare delivery.

In the Application segment, the management of cardiovascular diseases and diabetes is predominant, as these conditions require continuous monitoring to prevent complications. The increasing incidence of these chronic illnesses, coupled with the rising geriatric population, is propelling demand. Remote patient monitoring solutions are particularly beneficial in managing these conditions by providing timely alerts and reducing hospital visits. The trend towards personalized medicine and patient-centric care models is further enhancing the adoption of these applications.

The End User segment is primarily driven by hospitals and home care settings. Hospitals leverage remote patient monitoring to improve patient outcomes and optimize resource utilization, while home care settings benefit from the convenience and cost-effectiveness of managing chronic conditions outside traditional healthcare facilities. The shift towards value-based care and the emphasis on reducing healthcare costs are key trends supporting this segment. The increasing preference for home healthcare, especially among the elderly, is expected to sustain growth.

In the Component segment, software solutions are gaining prominence due to their role in data analytics, visualization, and integration with healthcare systems. These solutions are essential for transforming raw health data into actionable insights, thereby enhancing clinical decision-making. The demand for user-friendly interfaces and advanced analytics capabilities is driving innovation in this segment. The trend towards cloud-based solutions and the emphasis on cybersecurity to protect sensitive health data are critical factors influencing market dynamics.

Geographical Overview

North America: The remote patient monitoring market is highly mature, driven by advanced healthcare infrastructure and high chronic illness prevalence. The United States leads, with significant contributions from the healthcare and technology sectors. Canada also plays a notable role, with increasing adoption of telehealth solutions.

Europe: This region exhibits moderate market maturity, propelled by strong healthcare systems and supportive regulatory environments. Germany, the UK, and France are key players, with demand driven by aging populations and government initiatives to integrate digital health solutions.

Asia-Pacific: The market is rapidly growing, with countries like China, Japan, and India at the forefront. The demand is fueled by large populations, increasing chronic disease incidence, and government investments in healthcare technology. The region's diverse economic landscape presents both opportunities and challenges.

Latin America: The market is in its nascent stage, with Brazil and Mexico being the primary contributors. Growth is driven by improving healthcare infrastructure and rising awareness of digital health benefits. Economic constraints and regulatory hurdles remain challenges.

Middle East & Africa: The market is emerging, with the UAE and South Africa leading due to investments in healthcare modernization and digital health initiatives. The demand is driven by a growing burden of chronic diseases and efforts to improve healthcare accessibility.

Key Trends and Drivers

Trend 1 Title: Integration of AI and Machine Learning

The Remote Patient Monitoring (RPM) market for chronic illnesses is increasingly leveraging AI and machine learning to enhance data analysis and predictive capabilities. These technologies enable more accurate patient monitoring by identifying patterns and predicting potential health issues before they become critical. This integration allows healthcare providers to offer personalized care plans, improving patient outcomes and reducing hospital readmissions. As AI algorithms become more sophisticated, their application in RPM systems is expected to expand, driving market growth.

Trend 2 Title: Regulatory Support and Reimbursement Policies

Governments and healthcare regulators worldwide are recognizing the benefits of RPM in managing chronic illnesses, leading to supportive regulatory frameworks and reimbursement policies. These policies are crucial in encouraging healthcare providers to adopt RPM technologies by offsetting costs and ensuring compliance with health standards. The expansion of telehealth reimbursement codes and the inclusion of RPM services in insurance plans are significant drivers, making these technologies more accessible to a broader patient base.

Trend 3 Title: Increased Adoption of Wearable Devices

The proliferation of wearable health devices is a key trend in the RPM market, driven by advancements in sensor technology and consumer demand for health monitoring solutions. Wearables such as smartwatches and fitness trackers are increasingly equipped with capabilities to monitor vital signs, providing continuous data streams for chronic disease management. This trend is supported by the growing consumer health consciousness and the desire for proactive health management, which in turn fuels the demand for integrated RPM solutions.

Trend 4 Title: Expansion of Telehealth Services

The COVID-19 pandemic accelerated the adoption of telehealth services, which has had a lasting impact on the RPM market. Telehealth platforms are increasingly integrating RPM functionalities, allowing for seamless patient monitoring and virtual consultations. This expansion is driven by the need for remote healthcare solutions that provide convenience and reduce the burden on healthcare facilities. As telehealth becomes a standard component of healthcare delivery, RPM systems are expected to see increased integration and utilization.

Trend 5 Title: Focus on Chronic Disease Management

Chronic diseases such as diabetes, heart disease, and respiratory conditions are on the rise globally, creating a pressing need for effective management solutions. RPM technologies offer a viable solution by enabling continuous monitoring and timely interventions, which are critical in managing these conditions. The focus on chronic disease management is driving innovation in RPM technologies, with companies developing specialized solutions tailored to specific diseases. This trend is expected to continue as healthcare systems prioritize chronic disease management to improve patient outcomes and reduce healthcare costs.

Research Scope

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

Product Code: GIS32920

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Component
  • 2.6 Key Market Highlights by Application
  • 2.7 Key Market Highlights by Device
  • 2.8 Key Market Highlights by Deployment
  • 2.9 Key Market Highlights by End User

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Wearable Devices
    • 4.1.2 Implantable Devices
    • 4.1.3 External Monitoring Devices
    • 4.1.4 Others
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Blood Glucose Monitors
    • 4.2.2 Cardiac Monitors
    • 4.2.3 Respiratory Monitors
    • 4.2.4 Blood Pressure Monitors
    • 4.2.5 Temperature Monitors
    • 4.2.6 Multi-parameter Monitors
    • 4.2.7 Others
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Consultation Services
    • 4.3.2 Installation Services
    • 4.3.3 Maintenance Services
    • 4.3.4 Training Services
    • 4.3.5 Data Management Services
    • 4.3.6 Others
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Bluetooth
    • 4.4.2 Wi-Fi
    • 4.4.3 Cellular Networks
    • 4.4.4 Zigbee
    • 4.4.5 Others
  • 4.5 Market Size & Forecast by Component (2020-2035)
    • 4.5.1 Sensors
    • 4.5.2 Software
    • 4.5.3 Connectivity Technology
    • 4.5.4 Others
  • 4.6 Market Size & Forecast by Application (2020-2035)
    • 4.6.1 Diabetes Management
    • 4.6.2 Cardiovascular Disease Management
    • 4.6.3 Respiratory Disease Management
    • 4.6.4 Hypertension Management
    • 4.6.5 Others
  • 4.7 Market Size & Forecast by Device (2020-2035)
    • 4.7.1 Smartwatches
    • 4.7.2 Fitness Trackers
    • 4.7.3 Implantable Loop Recorders
    • 4.7.4 Continuous Glucose Monitors
    • 4.7.5 Others
  • 4.8 Market Size & Forecast by Deployment (2020-2035)
    • 4.8.1 Cloud-based
    • 4.8.2 On-premise
    • 4.8.3 Others
  • 4.9 Market Size & Forecast by End User (2020-2035)
    • 4.9.1 Hospitals
    • 4.9.2 Home Care Settings
    • 4.9.3 Ambulatory Care Centers
    • 4.9.4 Long-term Care Centers
    • 4.9.5 Others

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Component
      • 5.2.1.6 Application
      • 5.2.1.7 Device
      • 5.2.1.8 Deployment
      • 5.2.1.9 End User
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Component
      • 5.2.2.6 Application
      • 5.2.2.7 Device
      • 5.2.2.8 Deployment
      • 5.2.2.9 End User
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Component
      • 5.2.3.6 Application
      • 5.2.3.7 Device
      • 5.2.3.8 Deployment
      • 5.2.3.9 End User
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Component
      • 5.3.1.6 Application
      • 5.3.1.7 Device
      • 5.3.1.8 Deployment
      • 5.3.1.9 End User
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Component
      • 5.3.2.6 Application
      • 5.3.2.7 Device
      • 5.3.2.8 Deployment
      • 5.3.2.9 End User
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Component
      • 5.3.3.6 Application
      • 5.3.3.7 Device
      • 5.3.3.8 Deployment
      • 5.3.3.9 End User
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Component
      • 5.4.1.6 Application
      • 5.4.1.7 Device
      • 5.4.1.8 Deployment
      • 5.4.1.9 End User
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Component
      • 5.4.2.6 Application
      • 5.4.2.7 Device
      • 5.4.2.8 Deployment
      • 5.4.2.9 End User
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Component
      • 5.4.3.6 Application
      • 5.4.3.7 Device
      • 5.4.3.8 Deployment
      • 5.4.3.9 End User
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Component
      • 5.4.4.6 Application
      • 5.4.4.7 Device
      • 5.4.4.8 Deployment
      • 5.4.4.9 End User
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Component
      • 5.4.5.6 Application
      • 5.4.5.7 Device
      • 5.4.5.8 Deployment
      • 5.4.5.9 End User
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Component
      • 5.4.6.6 Application
      • 5.4.6.7 Device
      • 5.4.6.8 Deployment
      • 5.4.6.9 End User
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Component
      • 5.4.7.6 Application
      • 5.4.7.7 Device
      • 5.4.7.8 Deployment
      • 5.4.7.9 End User
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Component
      • 5.5.1.6 Application
      • 5.5.1.7 Device
      • 5.5.1.8 Deployment
      • 5.5.1.9 End User
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Component
      • 5.5.2.6 Application
      • 5.5.2.7 Device
      • 5.5.2.8 Deployment
      • 5.5.2.9 End User
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Component
      • 5.5.3.6 Application
      • 5.5.3.7 Device
      • 5.5.3.8 Deployment
      • 5.5.3.9 End User
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Component
      • 5.5.4.6 Application
      • 5.5.4.7 Device
      • 5.5.4.8 Deployment
      • 5.5.4.9 End User
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Component
      • 5.5.5.6 Application
      • 5.5.5.7 Device
      • 5.5.5.8 Deployment
      • 5.5.5.9 End User
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Component
      • 5.5.6.6 Application
      • 5.5.6.7 Device
      • 5.5.6.8 Deployment
      • 5.5.6.9 End User
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Component
      • 5.6.1.6 Application
      • 5.6.1.7 Device
      • 5.6.1.8 Deployment
      • 5.6.1.9 End User
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Component
      • 5.6.2.6 Application
      • 5.6.2.7 Device
      • 5.6.2.8 Deployment
      • 5.6.2.9 End User
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Component
      • 5.6.3.6 Application
      • 5.6.3.7 Device
      • 5.6.3.8 Deployment
      • 5.6.3.9 End User
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Component
      • 5.6.4.6 Application
      • 5.6.4.7 Device
      • 5.6.4.8 Deployment
      • 5.6.4.9 End User
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Component
      • 5.6.5.6 Application
      • 5.6.5.7 Device
      • 5.6.5.8 Deployment
      • 5.6.5.9 End User

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Philips Healthcare
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Medtronic
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 GE Healthcare
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Abbott Laboratories
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Boston Scientific
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Siemens Healthineers
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Johnson & Johnson
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 F. Hoffmann-La Roche
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Omron Healthcare
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Dexcom
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Biotronik
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Masimo Corporation
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 ResMed
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 iRhythm Technologies
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 BioTelemetry
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 AliveCor
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Hill-Rom Holdings
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Honeywell Life Sciences
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Welch Allyn
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 VivaLNK
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!